Dyne Therapeutics, Inc. Share Price & Technical Analysis
DYN · $19.33 (+4.15%)
Healthcare / Biotechnology
$19.33
+4.15%
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal musc…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-12% return in Jun, -8% avg return in past 3 year Jun month.
-4% return in 2026, 76% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -11% | 22% | -5% | 10% | -12% | – | – | – | – | – | – | -4% |
| 25 | -41% | -1% | -23% | 12% | 2% | -21% | 14% | 39% | -6% | 78% | -3% | -8% | 43% |
| 24 | 65% | 25% | 4% | -11% | 27% | 10% | 22% | 8% | 29% | -19% | 5% | -23% | 142% |
| 23 | 26% | -12% | -11% | -10% | 26% | -14% | 10% | -6% | -22% | -23% | 59% | 21% | 45% |
| 22 | -37% | 15% | 14% | -17% | -40% | 44% | 52% | -5% | 30% | -10% | 2% | -2% | 45% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.76B
P/E ratio
—
52W high
$25.00
52W low
$8.06
Volume
10,86,093
Beta
1.08
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Dyne Therapeutics, Inc. share price today?
- Dyne Therapeutics, Inc. (DYN) last traded around $19.33 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does DYN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for DYN. Download the app for real-time alerts.
- How can I analyze Dyne Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.